MC 2022 Isobutyric acid, sodium salt, [1-14C]- |
|
| (Sodium isobutyrate, [1-14C]-) | |
MORpure™ Delivered ≥ 98% pure with dated HPLC radiochromatogram |
|
| Aqueous solution, 100 μCi/ml | |
| > 50 mCi(1.85 GBq)/mmol | 50 μCi (1.85 MBq) $3970 |
| NextGen V-Vial | 250 μCi (9.25 MBq) $4680 |
| M.W. 110.09 | |
| This material is pharmaceutically unrefined, and not intended for use in humans, clinical diagnosis, or data derived from its use to support regulatory filings. | |
MC 2022L Isobutyric acid, sodium salt, [1-14C]- |
|
| (Sodium isobutyrate, [1-14C]-) | |
| Delivered ≥ 97% pure with dated HPLC radiochromatogram | |
| Aqueous solution, 100 μCi/ml | |
| > 20 mCi(0.74 GBq)/mmol | Please Inquire for Pricing |
| NextGen V-Vial | |
| M.W. 110.1 | |
| This material is pharmaceutically unrefined, and not intended for use in humans, clinical diagnosis, or data derived from its use to support regulatory filings. | |
MC 452 Isobutyric acid, [2-14C]- |
|
| (CH3)2CHCOOH | |
| Delivered ≥ 98% | |
| Dichloromethane solution, 100 μCi/ml | |
| > 45 mCi(1.665 GBq)/mmol | Please Inquire for Pricing |
| Sealed ampoule - shipped on dry ice | |
| M.W. 88.1 | |
| This material is pharmaceutically unrefined, and not intended for use in humans, clinical diagnosis, or data derived from its use to support regulatory filings. | |